Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

Biotechnology

Healthcare
$16.62 +0.58%

+$0.04 today

Market cap
$3.04B
Beta
0.90
P/E (TTM)
98.7
EPS (TTM)
$0.07
52W Low $4.40High $10.08

Volume 2.56M

Average 1.66M

Price history

Xeris Biopharma Holdings, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+142.98%

Period high

$16.99

Period low

$5.29

Latest

$16.62

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 6, 2026Nov 6, 2026
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
4Nov 4, 2026Nov 4, 2026
4Nov 4, 2026Nov 4, 2026
4Nov 4, 2026Nov 4, 2026
4Nov 4, 2026Nov 4, 2026
3Nov 4, 2026Nov 4, 2026
8-KNov 2, 2026Nov 2, 2026
SC 13G/AOct 30, 2026Oct 30, 2026
8-KOct 14, 2026Oct 14, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Sep 29, 2026Sep 29, 2026

Competitors

Who does Xeris Biopharma Holdings, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about XERS's filings, answered from its disclosures.

What is the latest XERS filing?

The latest filing shown is 4 dated Nov 6, 2026.

How many recent filings does XERS have?

Intrinsic Alpha currently shows 20 recent filings for XERS.